I de kontrollerede studier er der rapporteret om sløret syn hos flere patienter behandlet med pregabalin end hos patienter behandlet med placebo.
In controlled studies, a higher proportion of patients treated with pregabalin reported blurred vision than did patients treated with placebo which resolved in a majority of cases with continued dosing.